EFFECT OF SLEEP APNEA SYNDROME ON QT DISPERSION AND QT CORRECTED INTERVAL IN PATIENTS WITH TYPE 2 DIABETES

Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 1

Abstract

Objective. Prolonged QT interval and increased QT interval dispersion (QTd) are well-characterized precursor of malignant ventricular arrhythmias. The aim of the present study was to assess QT interval corrected for heart rate (QTc) and QTd in patients with type 2 diabetes and sleep apnea syndrome (SAS) comparative with patients with type 2 diabetes without sleep apnea. Methods. 52 subjects with type 2 diabetes were included in the study. According to apnea-hypopnea index (AHI) patients were divided into three groups: 1) control subjects (AHI < 5/hour of sleep); 2) patients with mild SAS (AHI=5-15/hour of sleep) and 3) patients with moderate–severe SAS (AHI≥15/hour of sleep). Bazett’s formula (QTc=QT/√RR) was used to obtain heart rate corrected values of the QT intervals and dispersions. Results. Prevalence of increased QTc interval in the whole population was 19.2% (10.5% in control group and 26.1% in moderate/severe SAS group). The mean QTd was 52.7 ms in all patients, with values increasing from 40.0 ms in controls to 64.8 ms in group with moderate-severe SAS. Statistically significant positive association was found between QTd and oxygen desaturation index (ODI) (β=0.38, p=0.006) and between QTd and AHI (β=0.29, p=0.03). In addition, a statistically significant negative association was found between QTd and mean SaO2 (β= -0.40, p=0.003) and between QTd and minimum SaO2 (β= -0.43, p=0.001). After adjustment for confounding factors, AHI, ODI, mean SaO2 and minimum SaO2 remained statistically significant associated with QTd. Conclusion. Sleep apnea is associated with changes in QT interval variability in patients with type 2 diabetes. Increased severity of SAS, as deter¬mined by AHI, may result in inhomogeneity of repolarization, favoring ventricular tachyarrhytmias.

Authors and Affiliations

Adriana Rusu, Cristina Nita, Cornelia Bala, Nicolae Hancu

Keywords

Related Articles

 THE RELATIONSHIP BETWEEN 1 HOUR GLYCEMIA, DURING ORAL GLUCOSE TOLERANCE TEST AND CARDIOMETABOLIC RISK

 Background Diabetes mellitus is a very common disease, worldwide there are currently over 366 million diabetics. It seems that people with normal glucose tolerance and blood glucose at 1 hour during OGTT ≥200mg% re...

EFFECT OF HLA-DR GENOTYPES ON THE CLINICAL MANIFESTATIONS AT THE ONSET OF TYPE 1 DIABETES IN A GROUP OF PATIENTS FROM CONSTANTA COUNTY

Type 1 diabetes mellitus (T1DM) is a metabolic disease with multifactorial etiology characterized by β-cell autoimmune processes. The strongest genetic determinants were proved to be class II genes of the major histocomp...

 RESISTIN AND HIGH GLUCOSE CONCENTRATIONS-ACTIVATION OF HUMAN SMOOTH MUSCLE CELLS INDUCES ENHANCED MONOCYTE CHEMOTAXIS

 Objectives. Recent data indicate that upon activation by resistin and high glucose concentrations (HG) vascular smooth muscle cells (SMC) acquire pro-inflammatory properties. We questioned whether resistin and HG-a...

 PANCREATIC INSULINOMA PRESENTING WITH POSTPRANDIAL HYPOGLICEMIAS

 We report the case of an obese 58 years old patient evaluated for hypoglycemia. The response to a prolonged fasting test was normal, but symptomatic hypoglycemia ensued after mixed meals and with oral glucose loadi...

MONITORING THE PROGRESSION OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH DIABETIC NEPHROPATHY- A PERMANENT CHALLENGE

Aim of study – The monitoring of renal function in 2 statistically comparative groups of patients, first group with diabetic kidney disease (DKD) and the second with non-diabetics patients with the same degree of chronic...

Download PDF file
  • EP ID EP124322
  • DOI -
  • Views 85
  • Downloads 0

How To Cite

Adriana Rusu, Cristina Nita, Cornelia Bala, Nicolae Hancu (2011). EFFECT OF SLEEP APNEA SYNDROME ON QT DISPERSION AND QT CORRECTED INTERVAL IN PATIENTS WITH TYPE 2 DIABETES. Romanian Journal of Diabetes Nutrition and Metabolic Diseases, 18(1), 5-12. https://www.europub.co.uk/articles/-A-124322